Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice

被引:111
作者
Anderson, CF [1 ]
Mendez, S [1 ]
Sacks, DL [1 ]
机构
[1] NIAID, NIH, Parasit Dis Lab, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.174.5.2934
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Experimental Leishmania major infection in mice has been of immense interest because it was among the first models to demonstrate the importance of the Th1/Th2 balance to infection outcome in vivo. However, the Th2 polarization that promotes the development of nonhealing cutaneous lesions in BALB/c mice has failed to adequately explain the mechanisms underlying nonhealing forms of leishmaniasis in humans. We have studied a L. major strain from a patient with northealing lesions that also produces nonhealing lesions with ulcerations and high parasite burden in conventionally resistant C57BL/6 mice. Surprisingly, these mice develop a strong, polarized, and sustained Th1 response, as evidenced by high levels of IFN-gamma, produced by Leishmania-specific cells in the draining lymph node and in the ear lesion, and an absence of IL-4 or IL-13. The parasites fail to be effectively cleared despite high level induction of inducible NO synthase in the lesion, and despite their sensitivity to killing by IFN-gamma-activated macrophages in vitro. Infection of IL-10(-/-) mice, blockade of the IL-10R, or depletion of CD25(+) cells during the chronic phase promotes parasite killing, indicating that IL-10 and regulatory T cells play a role in rendering the Th1 responses ineffective at controlling infection in the skin. Mice with nonhealing primary lesions are nonetheless resistant to reinfection in the other ear. We suggest that nonhealing infections in animal models that are explained not by aberrant Th2 development, but by overactivation of homeostatic pathways designed to control inflammation, provide better models to understand northealing or reactivation forms of leishmaniasis in humans.
引用
收藏
页码:2934 / 2941
页数:8
相关论文
共 41 条
[1]   IMMUNE-RESPONSES ASSOCIATED WITH SUSCEPTIBILITY OF C57BL/10 MICE TO LEISHMANIA-AMAZONENSIS [J].
AFONSO, LCC ;
SCOTT, P .
INFECTION AND IMMUNITY, 1993, 61 (07) :2952-2959
[2]   Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection [J].
Ajdary, S ;
Alimohammadian, MH ;
Eslami, MB ;
Kemp, K ;
Kharazmi, A .
INFECTION AND IMMUNITY, 2000, 68 (04) :1760-1764
[3]   Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma [J].
Akuffo, H ;
Maasho, K ;
Blostedt, M ;
Hojeberg, B ;
Britton, S ;
Bakhiet, M .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) :737-741
[4]   A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity [J].
Belkaid, Y ;
Mendez, S ;
Lira, R ;
Kadambi, N ;
Milon, G ;
Sacks, D .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :969-977
[5]   CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major [J].
Belkaid, Y ;
Von Stebut, E ;
Mendez, S ;
Lira, R ;
Caler, E ;
Bertholet, S ;
Udey, MC ;
Sacks, D .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3992-4000
[6]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[7]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[8]  
BELOSEVIC M, 1989, J IMMUNOL, V143, P266
[9]   Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice [J].
Carrera, L ;
Gazzinelli, RT ;
Badolato, R ;
Hieny, S ;
Muller, W ;
Kuhn, R ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :515-526
[10]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992